Chondromyxoid Fibroma of the Calcaneus: A Rare Case Report

Koray Başdelioğlu1, Mustafa İsmet Tatar2, Burak Çağrı Aksu1

  • 1Orthopedics and Traumatology, Faculty of Medicine, Yeditepe University, Istanbul, TUR.

Cureus
|March 14, 2022
PubMed

Insights

Chondromyxoid fibroma (CMF) of the calcaneus is rare but treatable. Curettage and bone grafting effectively resolved pain and restored function in a patient, suggesting CMF should be considered in heel pain diagnoses.

Area of Science:

  • Orthopedic Surgery
  • Musculoskeletal Oncology
  • Podiatric Medicine

Background:

  • Chondromyxoid fibroma (CMF) is a rare benign bone tumor.
  • CMF typically affects long bones, with calcaneal involvement being exceptionally uncommon.
  • Accurate diagnosis and effective treatment are crucial for patient outcomes.

Observation:

  • A 34-year-old female presented with a year of progressive heel pain and limping.
  • Imaging confirmed a lesion consistent with CMF of the calcaneus.
  • The patient underwent surgical treatment involving curettage and bone grafting.

Findings:

  • Post-operative recovery was rapid, with mobilization and weight-bearing permitted the day after surgery.
  • An 18-month follow-up revealed no signs of tumor recurrence.
  • The patient experienced complete pain relief and restoration of daily activities.

Implications:

  • Surgical curettage combined with bone grafting is an effective treatment for calcaneal CMF.
  • This case suggests that CMF of the calcaneus may be underdiagnosed.
  • Clinicians should consider CMF in the differential diagnosis for persistent heel pain.